» Articles » PMID: 16220453

Mechanisms of Disease: PI3K/AKT Signaling in Gastrointestinal Cancers

Overview
Journal Z Gastroenterol
Specialty Gastroenterology
Date 2005 Oct 13
PMID 16220453
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

The lipid kinase phosphoinositide 3-OH kinase (PI3K) and its downstream target Akt, also known as protein kinase B (PKB), are crucial effectors in oncogenic signaling induced by various receptor-tyrosine kinases. In recent years, data are accumulating that PI3K/Akt signaling components are frequently altered in a variety of human malignancies. This review summarizes the major effects of PI3K/Akt signaling on proliferation, survival and resistance to apoptosis, angiogenesis and cell motility in gastrointestinal cancers. In addition, activation of PI3K/Akt by various growth factors, the modulation of downstream targets by Akt-induced phosphorylation as well as novel treatment strategies targeting this pathway in gastrointestinal tumors are discussed.

Citing Articles

The essential roles of lncRNAs/PI3K/AKT axis in gastrointestinal tumors.

Li P, Ma X, Gu X Front Cell Dev Biol. 2024; 12:1442193.

PMID: 39161590 PMC: 11330846. DOI: 10.3389/fcell.2024.1442193.


Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies.

Shetu S, Bandyopadhyay D Int J Mol Sci. 2022; 23(7).

PMID: 35409064 PMC: 8999084. DOI: 10.3390/ijms23073706.


Roles of Nrf2 in Gastric Cancer: Targeting for Therapeutic Strategies.

Farkhondeh T, Pourbagher-Shahri A, Azimi-Nezhad M, Forouzanfar F, Brockmueller A, Ashrafizadeh M Molecules. 2021; 26(11).

PMID: 34070502 PMC: 8198360. DOI: 10.3390/molecules26113157.


Aptamer-SH2 superbinder-based targeted therapy for pancreatic ductal adenocarcinoma.

Liu A, Zhou J, Bi X, Hou G, Li S, Chen Q Clin Transl Med. 2021; 11(3):e337.

PMID: 33783993 PMC: 7908048. DOI: 10.1002/ctm2.337.


The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication.

Padua D, Figueira P, Ribeiro I, Almeida R, Mesquita P Front Cell Dev Biol. 2020; 8:442.

PMID: 32626705 PMC: 7314965. DOI: 10.3389/fcell.2020.00442.